Frontotemporal Dementia Clinical Trials 2024

Frontotemporal Dementia Clinical Trials 2024

Frontotemporal Dementia research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in frontotemporal dementia clinical trials today.

Frontotemporal Dementia Clinical Trials

Here are the 6 most popular medical studies for frontotemporal dementia

Popular filter options for frontotemporal dementia trials

FTD Clinical Trials

View 28 FTD medical studies.

Primary Progressive Aphasia Clinical Trials

View 24 Primary Progressive Aphasia medical studies.

Frontotemporal Dementia Clinical Trials With No Placebo

View 57 frontotemporal dementia medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to frontotemporal dementia

What are the top hospitals conducting frontotemporal dementia research?

Frontotemporal dementia, a complex neurodegenerative condition affecting the frontal and temporal lobes of the brain, has spurred top hospitals across the United States to spearhead groundbreaking clinical trials. In Philadelphia, the University of Pennsylvania leads with an impressive seven active trials focused on frontotemporal dementia, accompanied by a total of 23 trials in their journey thus far. Their pioneering efforts began back in 2003 when they recorded their first trial dedicated to understanding this debilitating disease. Similarly committed to advancing research is Mayo Clinic in Rochester, where six ongoing clinical trials are shedding light on frontotemporal dementia. With a history encompassing 15 previously conducted studies since their inaugural trial in 2008, Mayo Clinic continues to push boundaries and expand our knowledge of this perplexing condition.

Not far behind is Massachusetts General Hospital located amidst Boston's medical hub that actively engages with four current frontotemporal dementia trials while boasting ten successful past investigations from as recent as2011 onwards; proving its dedication towards unraveling mysteries surrounding this disorder.Johns Hopkins Hospital based out of Baltimore also joins the ranks with four active clinical tests underway for frontotemporal dementia care-needs along with notable contribution having accomplished five previous experiments starting revelations through it's initial study undertaken at around2007 inception.Furthermore,the University of California San Francisco demonstrates its commitment by conducting three ongoing clinical trials aimed at investigating frontotemporal dementia, adding insights sourced from seven prior studies initiated since recording their first trial just aboutseven years ago,in2014.

The tireless efforts showcased by these leading institutions emphasize not only progress but promise for individuals affected by frontotemporal dementia worldwide. Each study serves as a stepping-stone toward breakthroughs that can potentially enhance patient outcomes and improve quality of life for those living with this challenging condition

Which are the best cities for frontotemporal dementia clinical trials?

When it comes to frontotemporal dementia clinical trials, several cities stand out for their research efforts. San Francisco, California leads the way with 11 active trials focusing on treatments like AL001 and Care Ecosystem. Philadelphia, Pennsylvania follows closely behind with 10 ongoing studies exploring interventions such as Online training sites and Low-Intensity Prompts. Rochester, Minnesota is another notable city with 9 active trials investigating therapies like Algorithmically Matched approaches and Pittsburgh Compound B (C-11 PiB). These cities, along with Baltimore, Maryland and Toronto, Ontario offer individuals affected by frontotemporal dementia access to cutting-edge clinical trials that contribute to advancements in care for this challenging condition.

Which are the top treatments for frontotemporal dementia being explored in clinical trials?

Frontotemporal dementia, a complex neurological disorder, is the focus of intensive clinical research. Currently, two treatments are making waves in active trials. AL001 takes the lead with its involvement in two ongoing studies and three all-time frontotemporal dementia trials since 2018. Additionally, bilateral subgenual cingulate deep brain stimulation (SGC DBS) and Care Ecosystem have both recently entered the scene with one active trial each and first listings in 2023. As researchers delve deeper into understanding this challenging condition, these innovative approaches hold promise for improving treatment outcomes for individuals affected by frontotemporal dementia.

What are the most recent clinical trials for frontotemporal dementia?

Exciting developments are underway in the field of frontotemporal dementia, with recent clinical trials offering hope for improved treatments. One trial is examining the effects of remotely supervised tdcs (transcranial direct current stimulation) combined with word-naming practice as a potential intervention. Another study is investigating the use of N-Acetyl-L-Leucine, aiming to determine its efficacy in treating frontotemporal dementia. Additionally, verdiperstat is being evaluated in a Phase 1 trial to assess its impact on this neurodegenerative disorder. These innovative trials provide valuable insights and hold promise for advancing our understanding and treatment options for individuals affected by frontotemporal dementia.

What frontotemporal dementia clinical trials were recently completed?

In the realm of frontotemporal dementia research, a notable clinical trial investigating the potential of Lithium Carbonate has recently concluded. Sponsored by Columbia University, this trial reached completion in January 2017. While more recent trials may be underway or pending results, this study represents an important effort to advance our understanding and treatment options for frontotemporal dementia.